Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 5
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer.
Woodcock VK, Chen JL, Purshouse K, Butcher C, Collins L, Haddon C, Verrall G, Elhussein L, Roberts C, Tarlton A, Rei M, Napolitani G, Salio M, Middleton MR, Cerundolo V, Crew J, Protheroe AS. Woodcock VK, et al. Among authors: elhussein l. BJUI Compass. 2023 Jan 13;4(3):322-330. doi: 10.1002/bco2.220. eCollection 2023 May. BJUI Compass. 2023. PMID: 37025470 Free PMC article.
Estimating the Incidence and Key Risk Factors of Cardiovascular Disease in Patients at High Risk of Imminent Fracture Using Routinely Collected Real-World Data From the UK.
Pineda-Moncusí M, El-Hussein L, Delmestri A, Cooper C, Moayyeri A, Libanati C, Toth E, Prieto-Alhambra D, Khalid S. Pineda-Moncusí M, et al. J Bone Miner Res. 2022 Oct;37(10):1986-1996. doi: 10.1002/jbmr.4648. Epub 2022 Sep 8. J Bone Miner Res. 2022. PMID: 35818312 Free PMC article.
Predicting Imminent Fractures in Patients With a Recent Fracture or Starting Oral Bisphosphonate Therapy: Development and International Validation of Prognostic Models.
Khalid S, Pineda-Moncusí M, El-Hussein L, Delmestri A, Ernst M, Smith C, Libanati C, Toth E, Javaid MK, Cooper C, Abrahamsen B, Prieto-Alhambra D. Khalid S, et al. J Bone Miner Res. 2021 Nov;36(11):2162-2176. doi: 10.1002/jbmr.4414. Epub 2021 Aug 30. J Bone Miner Res. 2021. PMID: 34342378 Free article.
Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.
Robinson DE, Ali MS, Strauss VY, Elhussein L, Abrahamsen B, Arden NK, Ben-Shlomo Y, Caskey F, Cooper C, Dedman D, Delmestri A, Judge A, Javaid MK, Prieto-Alhambra D. Robinson DE, et al. Among authors: elhussein l. Health Technol Assess. 2021 Mar;25(17):1-106. doi: 10.3310/hta25170. Health Technol Assess. 2021. PMID: 33739919 Free PMC article.
Safety of Oral Bisphosphonates in Moderate-to-Severe Chronic Kidney Disease: A Binational Cohort Analysis.
Robinson DE, Ali MS, Pallares N, Tebé C, Elhussein L, Abrahamsen B, Arden NK, Ben-Shlomo Y, Caskey FJ, Cooper C, Dedman D, Delmestri A, Judge A, Pérez-Sáez MJ, Pascual J, Nogues X, Diez-Perez A, Strauss VY, Javaid MK, Prieto-Alhambra D. Robinson DE, et al. Among authors: elhussein l. J Bone Miner Res. 2021 May;36(5):820-832. doi: 10.1002/jbmr.4235. Epub 2021 Feb 8. J Bone Miner Res. 2021. PMID: 33373491 Free article.
Effect of Athena SWAN funding incentives on women's research leadership.
Ovseiko PV, Taylor M, Gilligan RE, Birks J, Elhussein L, Rogers M, Tesanovic S, Hernandez J, Wells G, Greenhalgh T, Buchan AM. Ovseiko PV, et al. Among authors: elhussein l. BMJ. 2020 Oct 26;371:m3975. doi: 10.1136/bmj.m3975. BMJ. 2020. PMID: 33106283 No abstract available.
A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol.
Brown NF, Ng SM, Brooks C, Coutts T, Holmes J, Roberts C, Elhussein L, Hoskin P, Maughan T, Blagden S, Mulholland P. Brown NF, et al. Among authors: elhussein l. BMC Cancer. 2020 Mar 12;20(1):198. doi: 10.1186/s12885-020-6624-y. BMC Cancer. 2020. PMID: 32164579 Free PMC article. Clinical Trial.
Oral Bisphosphonate Use and All-Cause Mortality in Patients With Moderate-Severe (Grade 3B-5D) Chronic Kidney Disease: A Population-Based Cohort Study.
Alarkawi D, Ali MS, Bliuc D, Pallares N, Tebe C, Elhussein L, Caskey FJ, Arden NK, Ben-Shlomo Y, Abrahamsen B, Diez-Perez A, Pascual J, Pérez-Sáez MJ, Center JR, Judge A, Cooper C, Javaid MK, Prieto-Alhambra D. Alarkawi D, et al. Among authors: elhussein l. J Bone Miner Res. 2020 May;35(5):894-900. doi: 10.1002/jbmr.3961. Epub 2020 Feb 18. J Bone Miner Res. 2020. PMID: 31968134 Free article.
12 results